Clinical trials are a type of research that studies new tests (outcome measures) and treatments and evaluates their effects on human health outcomes. To learn more about clinical trials and how to participates click the button below.
To learn more about current trials and studies see: Current Trials and Studies | FSHD Society or Search for: Other terms: facioscapulohumeral, Recruiting studies | Card Results | ClinicalTrials.gov
| Trial name | Drug | Company | Phase | Status | Trial sites in Europe | More information |
| REINFORCE | Satralizumab | Centre Hospitalier Universitaire de Nice | Phase 2 | Recruiting | France | Study Details | Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1 | ClinicalTrials.gov |
| MANOEUVRE | RO7204239 | Roche | Phase 2 | Active, not Recruiting | Denmark, Italy, UK | Study Details | A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy | ClinicalTrials.gov |
| FORTITUDE | AOC 1020 | Avidity | Phase 1/ 2 | Recruiting | UK |
|
| Arrowhead | ARO-DUX4 | Arrowhead | Phase 1/2 | Recruiting | Not yet in Europe | Study Details | Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1 | ClinicalTrials.gov |
|
REACH
|
Losmapimod | Fulcrum | Phase 3 | Suspended | Denmark, France, Germany, Italy, Netherlands, Spain, UK | Study Details | Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) | ClinicalTrials.gov |